2019-ncov Pneumonia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-03-17
Clinical Trial Update: A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia [Phase 3]
Phase 3 randomized, open-label study evaluating ASC09F with ritonavir for 2019-nCoV pneumonia (COVID-19).